282 related articles for article (PubMed ID: 36018495)
21. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation.
Ghelardi E; Celandroni F; Salvetti S; Gueye SA; Lupetti A; Senesi S
J Appl Microbiol; 2015 Aug; 119(2):552-9. PubMed ID: 25973914
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy.
Senesi S; Celandroni F; Tavanti A; Ghelardi E
Appl Environ Microbiol; 2001 Feb; 67(2):834-9. PubMed ID: 11157251
[TBL] [Abstract][Full Text] [Related]
23. Pre- and probiotic overview.
Cremon C; Barbaro MR; Ventura M; Barbara G
Curr Opin Pharmacol; 2018 Dec; 43():87-92. PubMed ID: 30219638
[TBL] [Abstract][Full Text] [Related]
24. Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii.
Cenci G; Trotta F; Caldini G
J Appl Microbiol; 2006 Dec; 101(6):1208-15. PubMed ID: 17105550
[TBL] [Abstract][Full Text] [Related]
25. Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.
Paparo L; Tripodi L; Bruno C; Pisapia L; Damiano C; Pastore L; Berni Canani R
Sci Rep; 2020 Jul; 10(1):12636. PubMed ID: 32724066
[TBL] [Abstract][Full Text] [Related]
26.
Madempudi RS; Neelamraju J; Ahire JJ; Muthukumar M; Rudrappa S; Gopal G; Nagendra K
Benef Microbes; 2022 Oct; 13(4):331-340. PubMed ID: 36004716
[TBL] [Abstract][Full Text] [Related]
27. The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies.
Gorreja F; Walker WA
Gut Microbes; 2022; 14(1):2149214. PubMed ID: 36469568
[TBL] [Abstract][Full Text] [Related]
28. Bacillus clausii UBBC-07 reduces severity of diarrhoea in children under 5 years of age: a double blind placebo controlled study.
Sudha MR; Jayanthi N; Pandey DC; Verma AK
Benef Microbes; 2019 Mar; 10(2):149-154. PubMed ID: 30638396
[TBL] [Abstract][Full Text] [Related]
29. Role of Probiotics in Human Gut Microbiome-Associated Diseases.
Kim SK; Guevarra RB; Kim YT; Kwon J; Kim H; Cho JH; Kim HB; Lee JH
J Microbiol Biotechnol; 2019 Sep; 29(9):1335-1340. PubMed ID: 31434172
[TBL] [Abstract][Full Text] [Related]
30. Role of a probiotic strain in the modulation of gut microbiota and cytokines in inflammatory bowel disease.
Bamola VD; Dubey D; Samanta P; Kedia S; Ahuja V; Madempudi RS; Neelamraju J; Chaudhry R
Anaerobe; 2022 Dec; 78():102652. PubMed ID: 36198385
[TBL] [Abstract][Full Text] [Related]
31. Microbiota in Functional Gastrointestinal Disorders in Infancy: Implications for Management.
Abrahamsson TR; Wu RY; Sherman PM
Nestle Nutr Inst Workshop Ser; 2017; 88():107-115. PubMed ID: 28346927
[TBL] [Abstract][Full Text] [Related]
32. Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration.
Parker EA; Roy T; D'Adamo CR; Wieland LS
Nutrition; 2018 Jan; 45():125-134.e11. PubMed ID: 28870406
[TBL] [Abstract][Full Text] [Related]
33. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
[TBL] [Abstract][Full Text] [Related]
34. Bio-removal of tetracycline antibiotics under the consortium with probiotics Bacillus clausii T and Bacillus amyloliquefaciens producing biosurfactants.
Liu CX; Xu QM; Yu SC; Cheng JS; Yuan YJ
Sci Total Environ; 2020 Mar; 710():136329. PubMed ID: 31918182
[TBL] [Abstract][Full Text] [Related]
35. Bacillus Clausii Septicemia in a Pediatric Patient After Treatment With Probiotics.
Joshi S; Udani S; Sen S; Kirolikar S; Shetty A
Pediatr Infect Dis J; 2019 Sep; 38(9):e228-e230. PubMed ID: 31033906
[TBL] [Abstract][Full Text] [Related]
36. Role of Probiotics in Managing Gastrointestinal Dysfunction in Children with Autism Spectrum Disorder: An Update for Practitioners.
Patusco R; Ziegler J
Adv Nutr; 2018 Sep; 9(5):637-650. PubMed ID: 30202938
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo evaluation of Bacillus clausii against Schistosoma mansoni.
Cruz CS; França WWM; de Arújo HDA; Ximenes ECPA; de Souza VM; Albuquerque MCPA; Aires AL; Costa VMA
Acta Trop; 2022 Nov; 235():106669. PubMed ID: 36037981
[TBL] [Abstract][Full Text] [Related]
38. Bacillus clausii for Prevention of Late-onset Sepsis in Preterm Infants: A Randomized Controlled Trial.
Tewari VV; Dubey SK; Gupta G
J Trop Pediatr; 2015 Oct; 61(5):377-85. PubMed ID: 26246087
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India.
Lahiri KR; Singh R; Apte M; Patil M; Taksande A; Varona R; Chatterjee G; Verma M; Brette S; Perez MI
Trop Dis Travel Med Vaccines; 2022 Apr; 8(1):9. PubMed ID: 35397572
[TBL] [Abstract][Full Text] [Related]
40. Probiotics, gut microbiota, and their influence on host health and disease.
Sánchez B; Delgado S; Blanco-Míguez A; Lourenço A; Gueimonde M; Margolles A
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27500859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
